NU-2058

An ATP-competitive inhibitor of CDK1 and CDK2 with Ki of 5 uM and 12 uM respectively; inhibits human tumor cells with a mean GI50 of 13±7 uM.

161058-83-9

≥ 2 years

>98% (HPLC)

247.2963

C12H17N5O

Research use only, not for human use.

CDK1|CDK2|TopoII

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-70686G 0.1 mL

Ask

YF-MA16221 100 ug

Ask

AF2127 100 µg

Ask

MBS6031486-01 0.5 mL

Ask

MBS6031486-02 5x 0.5 mL

Ask

BZ66368 1 Vial

Ask